[1] Huang YQ, Wang Y, Wang H, Liu ZR, Yu X, Yan J, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry 2019;6(3):211 − 24. http://dx.doi.org/10.1016/S2215-0366(18)30511-XCrossRef
[2] Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 2013;382(9904):1575 − 86. http://dx.doi.org/10.1016/S0140-6736(13)61611-6CrossRef
[3] GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990−2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1859 − 922. http://dx.doi.org/10.1016/S0140-6736(18)32335-3CrossRef
[4] Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(5):593 − 602. http://dx.doi.org/10.1001/archpsyc.62.6.593CrossRef
[5] Xu JF, Wang J, Wimo A, Qiu CX. The economic burden of mental disorders in China, 2005–2013: implications for health policy. BMC Psychiatry 2016;16:137. http://dx.doi.org/10.1186/s12888-016-0839-0CrossRef
[6] Wang PS, Berglund P, Olfson M, Pincus HA, Wells KB, Kessler RC. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):603 − 13. http://dx.doi.org/10.1001/archpsyc.62.6.603CrossRef
[7] Chen RZ, Wu XM, Ma N. Mental health policy and implementation from 2009 to 2019 in China. Chin Men Health J 2020; 34(7): 555-60. https://kns.cnki.net/kcms/detail/11.1873.R.20200624.1402.002.html. (In Chinese). https://kns.cnki.net/kcms/detail/11.1873.R.20200624.1402.002.html